These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3784749)

  • 1. The Avitene pack: a new method to control epistaxis in a patient with poor platelet function.
    Keen M
    Laryngoscope; 1986 Dec; 96(12):1411. PubMed ID: 3784749
    [No Abstract]   [Full Text] [Related]  

  • 2. Microfibrillar collagen (Avitene) as a hemostatic agent in experimental oral wounds.
    Alexander JM; Rabinowitz JL
    J Oral Surg; 1978 Mar; 36(3):202-5. PubMed ID: 272452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avitene -- its value in the control of anterior epistaxis.
    Taylor MT
    J Otolaryngol; 1980 Dec; 9(6):468-71. PubMed ID: 7193745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic percutaneous embolization in intractable epistaxis.
    Sokoloff J; Wickbom I; McDonald D; Brahme F; Goergen TC; Goldberger LE
    Radiology; 1974 May; 111(2):285-7. PubMed ID: 4818964
    [No Abstract]   [Full Text] [Related]  

  • 5. Update on epistaxis.
    Douglas R; Wormald PJ
    Curr Opin Otolaryngol Head Neck Surg; 2007 Jun; 15(3):180-3. PubMed ID: 17483687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies in the specialist management of adult epistaxis: an evidence-based review.
    Spielmann PM; Barnes ML; White PS
    Clin Otolaryngol; 2012 Oct; 37(5):382-9. PubMed ID: 23164264
    [No Abstract]   [Full Text] [Related]  

  • 7. Combine Marocel and Gelfilm as a nasal pack.
    Leek JH
    Laryngoscope; 1985 Jan; 95(1):99. PubMed ID: 3965840
    [No Abstract]   [Full Text] [Related]  

  • 8. Superselective embolisation for intractable idiopathic epistaxis.
    Oguni T; Korogi Y; Yasunaga T; Sadanaga T; Uozumi H; Kawanaka K; Sumi S; Takahashi M
    Br J Radiol; 2000 Nov; 73(875):1148-53. PubMed ID: 11144790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of FloSeal haemostatic agent in the management of epistaxis.
    Khan MK; Reda El Badawey M; Powell J; Idris M
    J Laryngol Otol; 2015 Apr; 129(4):353-7. PubMed ID: 25776997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemostatic absorbable gel matrix for severe post-traumatic epistaxis].
    Bachelet JT; Bourlet J; Gleizal A
    Rev Stomatol Chir Maxillofac Chir Orale; 2013 Nov; 114(5):310-4. PubMed ID: 24028779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial embolization with use of lipiodol and gelatin sponge for active nasal bleeding from hepatocellular carcinoma metastasis in the pituitary gland.
    Takigawa T; Matsumaru Y; Hayakawa M; Ikeda K; Matsumura A
    Neurol Med Chir (Tokyo); 2011; 51(8):592-5. PubMed ID: 21869584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the use of Floseal haemostatic matrix in the treatment of epistaxis: a prospective, control-matched longitudinal study.
    Lau AS; Upile NS; Lazarova L; Swift AC
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2579-84. PubMed ID: 26920703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status and advances in transcatheter selective arterial embolization in the head and neck].
    He ZL; Zhang ZK
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1989 Sep; 24(5):312-4. PubMed ID: 2517940
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of Persistent Epistaxis Using Floseal Hemostatic Matrix vs. traditional nasal packing: a prospective randomized control trial.
    Murray S; Mendez A; Hopkins A; El-Hakim H; Jeffery CC; Côté DWJ
    J Otolaryngol Head Neck Surg; 2018 Jan; 47(1):3. PubMed ID: 29310703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Floseal: A novel application technique for the treatment of challenging epistaxis.
    Bonduelle Q; Biggs TC; Sipaul F
    Clin Otolaryngol; 2020 Nov; 45(6):960-962. PubMed ID: 32608145
    [No Abstract]   [Full Text] [Related]  

  • 16. Domiciliary floseal prevents admission for epistaxis in hereditary hemorrhagic telangiectasia.
    Warner L; Halliday J; James K; de Carpentier J
    Laryngoscope; 2014 Oct; 124(10):2238-40. PubMed ID: 24706356
    [No Abstract]   [Full Text] [Related]  

  • 17. On the effectiveness of treatment options in epistaxis: an analysis of 678 interventions.
    Soyka MB; Nikolaou G; Rufibach K; Holzmann D
    Rhinology; 2011 Oct; 49(4):474-8. PubMed ID: 21991575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of hemostatic agents in experimental splenic lacerations.
    Coln D; Horton J; Ogden ME; Buja LM
    Am J Surg; 1983 Feb; 145(2):256-9. PubMed ID: 6687418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous embolization to control intractable epistaxis.
    Wills PI; Russell RD
    Laryngoscope; 1979 Sep; 89(9 Pt 1):1385-8. PubMed ID: 481044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study on the hemostatic properties of collagen sponge].
    Wang YS; Hou CL; Chen AM
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 May; 15(3):140-3. PubMed ID: 11393951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.